For over 40 years, MEDRAD has been on the leading edge of innovation for controlled fluid delivery in diagnostic imaging. MEDRAD developed the first true flow-rate controlled Angiography Injection System in 1966, the first commercially successful CT Injection System in 1984, the first commercially successful MR Injection System in 1996, the first MR-compatible infusion system in 2002, and the first PET Infusion System in 2008.
The growth of nuclear medicine has been exponential over the past ten years. In 2000, a few hundred thousand procedures were performed. By 2008, this number had increased to approximately 1.8 million. Experts predict that over 5.6 million PET scans will be performed in 2016.¹
As PET procedures continue to grow, workflow and radiation exposure may become increasingly difficult to manage. The Intego PET Infusion System offers a Precise, Flexible, Safe, and Efficient solution.
• Accurate, repeatable FDG administration: ±2% of measured dose
• Integrated dose calibrator with intelligent fluid control and management technology
• User configurable formulas for weight-based dosing
• Real-time, automated dose preparation and infusion – directly from multi-dose vials containing up to 700 mCi
• Dose-on-demand technology through simple touchscreen
• Programmable dose range: 1-25 mCi
• Reduced exposure from dose preparation and/or handling
• Effective shielding: <2 mRem/hour @ 12 inches from all surfaces
• Custom designed shipping containers, vial shields, and disposables to minimize exposure
• Test inject, low flow rate and low pressure ensure added patient safety
• Reduced number of steps and time spent for dose preparation and infusion
• Simple, automated record keeping
• Automated linearity and quality control features
¹ ”Market for PET Radiopharmaceuticals and PET Imaging”, prepared by Bio-Tech Systems, Inc., July 2009